C000175523 Performance — Patient Opportunity Trust, Class I

Data updated: 2024-03-15

C000175523 returned +39.58% over one year to Dec 2023. The annualised 3-year return is −4.63%. Against its US Multi-Cap Growth category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $87, against $106 for the category, and to $140 over one year, against $126. Volatility over the past three years was 29.83% a year. In the 12 months to Dec 2023 the fund took in a net $2.7B, and assets reached $1.38B.

C000175523 Growth of $100

What $100 invested in Patient Opportunity Trust grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Growth category average over the same months.

PeriodC000175523Category average
1 year (Jan 2023 – Dec 2023)$140$126
3 years (Jan 2021 – Dec 2023)$87$106
Since data start (Jul 2019 – Dec 2023)$141$156

C000175523 Trailing Returns

Total returns to Dec 2023, from SEC N-PORT.

PeriodTotal return
1 year+39.58%
3 years (annualised)−4.63%

C000175523 Annual Returns

Calendar-year total returns of Patient Opportunity Trust, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2023+39.58%
2022−35.92%
2021−3.01%
2020+38.92%
2019 (Jul–Dec)+16.68%

C000175523 Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2023+20.9%−4.6%−4.4%−1.9%+2.3%+13.4%+7.9%−7.9%−5.2%−8.2%+13.7%+13.2%
2022−6.0%−2.7%+1.7%−10.8%−4.1%−17.5%+10.7%+0.5%−14.0%+10.5%+5.1%−12.1%
2021+8.0%+7.6%+0.4%+3.6%−0.7%+1.2%−6.0%−4.3%−4.5%+2.1%−7.0%−2.2%
2020−2.5%−11.5%−29.2%+23.9%+7.8%+10.5%+9.8%+9.5%−5.6%−0.4%+24.2%+9.8%
2019——————+2.7%−7.8%+3.7%+7.4%+9.4%+1.1%

C000175523 Risk

Risk measures from monthly returns over Jan 2021 – Dec 2023.

  • 3-year volatility (annualised): 29.83%
  • 3-year Sharpe ratio: -0.31 (vs 4.5% risk-free rate)
  • Best month: +20.90% (Jan 2023)
  • Worst month: −17.53% (Jun 2022)

C000175523 Fund Flows

Monthly money in and out of Patient Opportunity Trust, from SEC Form N-PORT.

  • 12-month net flow: $2.7B
  • 12-month gross sales (incl. reinvestments): $1.3B
  • Sales ÷ redemptions: -0.89×
MonthSalesRedemptionsNet flow
Dec 2023$7.3M−$22.0M$29.2M
Nov 2023$7.8M−$20.9M$28.6M
Oct 2023$6.4M−$29.3M$35.7M
Sep 2023$4.8M−$15.2M$20.0M
Aug 2023$12.2M−$20.7M$32.9M
Jul 2023$5.4M−$15.3M$20.7M
Jun 2023$10.4M−$24.3M$34.7M
May 2023$1.2B−$1.2B$2.4B
Apr 2023$6.4M−$17.0M$23.5M
Mar 2023$10.2M−$25.0M$35.2M
Feb 2023$8.6M−$32.5M$41.1M
Jan 2023$16.4M−$24.6M$41.0M

C000175523 Assets Under Management

Net assets of Patient Opportunity Trust by report date, from SEC N-PORT filings.

Report dateNet assets
2023-12-31$1.38B
2023-09-30$1.22B
2023-06-30$1.32B
2023-03-31$1.20B
2022-12-31$1.13B
2022-09-30$1.21B
2022-06-30$1.34B
2022-03-31$1.97B
2021-12-31$2.19B
2021-09-30$2.41B
2021-06-30$2.88B
2021-03-31$2.69B

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.